Effects of a nebulized NONOate, DPTA/NO, on group B Streptococcus-induced pulmonary hypertension in newborn piglets

Katarzyna Dabrowska, Dorothy Hehre, Karen C. Young, Cristina Navarette, John F. Ladino, Eduardo Bancalari, Cleide Suguihara

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

NONOates are chemical compounds that are stable as solids but generate nitric oxide (NO) in aqueous solutions. When nebulized or instilled intratracheally, NONOates can attenuate pulmonary hypertension in adult animals with lung injury. To assess the effect of a nebulized NONOate, DPTA/NO, on group B Streptococcus (GBS)-induced pulmonary hypertension in newborn piglets, we studied 20 anesthetized and mechanically ventilated piglets (4-10 d). They were randomly assigned to receive nebulized placebo solution or DPTA/NO (100 mg) 15 min after sustained pulmonary hypertension. Pulmonary artery and wedge, systemic, and right atrial pressures; cardiac output; and arterial blood gases were obtained at baseline and every 15 min during 120 min of continuous GBS infusion (6 × 108 CFU/min). Methemoglobin levels were measured at baseline and 60 min. A significant decrease in pulmonary artery pressure, pulmonary vascular resistance (PVR), systemic arterial pressure, and systemic vascular resistance (SVR) was observed after DPTA/NO nebulization (p < 0.001). Whereas the increase in PVR/SVR observed after GBS infusion was sustained for 120 min in the placebo group, this ratio decreased after DPTA/NO nebulization and remained significantly lower throughout the study period (p < 0.01). Cardiac output, arterial blood gases, and methemoglobin values did not differ between groups. These data demonstrate that the pulmonary hypertension induced by GBS infusion is markedly attenuated by DPTA/NO nebulization. The lower PVR/SVR observed in the treated group indicates that the vasodilatory effect of NONOate is more pronounced in the pulmonary than systemic vasculature. Therefore, NONOates may have clinical application in the management of pulmonary hypertension secondary to sepsis in neonates.

Original languageEnglish (US)
Pages (from-to)378-383
Number of pages6
JournalPediatric Research
Volume57
Issue number3
DOIs
StatePublished - Mar 1 2005
Externally publishedYes

Fingerprint

Streptococcus agalactiae
Pulmonary Hypertension
Vascular Resistance
Nitric Oxide
Methemoglobin
Cardiac Output
Pulmonary Artery
Gases
Placebos
Atrial Pressure
Lung Injury
dipropylenetriamine-NONOate
Sepsis
Arterial Pressure
Pressure
Lung

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

Dabrowska, Katarzyna ; Hehre, Dorothy ; Young, Karen C. ; Navarette, Cristina ; Ladino, John F. ; Bancalari, Eduardo ; Suguihara, Cleide. / Effects of a nebulized NONOate, DPTA/NO, on group B Streptococcus-induced pulmonary hypertension in newborn piglets. In: Pediatric Research. 2005 ; Vol. 57, No. 3. pp. 378-383.
@article{e5c27a7d562943ee9494b98af63bd32d,
title = "Effects of a nebulized NONOate, DPTA/NO, on group B Streptococcus-induced pulmonary hypertension in newborn piglets",
abstract = "NONOates are chemical compounds that are stable as solids but generate nitric oxide (NO) in aqueous solutions. When nebulized or instilled intratracheally, NONOates can attenuate pulmonary hypertension in adult animals with lung injury. To assess the effect of a nebulized NONOate, DPTA/NO, on group B Streptococcus (GBS)-induced pulmonary hypertension in newborn piglets, we studied 20 anesthetized and mechanically ventilated piglets (4-10 d). They were randomly assigned to receive nebulized placebo solution or DPTA/NO (100 mg) 15 min after sustained pulmonary hypertension. Pulmonary artery and wedge, systemic, and right atrial pressures; cardiac output; and arterial blood gases were obtained at baseline and every 15 min during 120 min of continuous GBS infusion (6 × 108 CFU/min). Methemoglobin levels were measured at baseline and 60 min. A significant decrease in pulmonary artery pressure, pulmonary vascular resistance (PVR), systemic arterial pressure, and systemic vascular resistance (SVR) was observed after DPTA/NO nebulization (p < 0.001). Whereas the increase in PVR/SVR observed after GBS infusion was sustained for 120 min in the placebo group, this ratio decreased after DPTA/NO nebulization and remained significantly lower throughout the study period (p < 0.01). Cardiac output, arterial blood gases, and methemoglobin values did not differ between groups. These data demonstrate that the pulmonary hypertension induced by GBS infusion is markedly attenuated by DPTA/NO nebulization. The lower PVR/SVR observed in the treated group indicates that the vasodilatory effect of NONOate is more pronounced in the pulmonary than systemic vasculature. Therefore, NONOates may have clinical application in the management of pulmonary hypertension secondary to sepsis in neonates.",
author = "Katarzyna Dabrowska and Dorothy Hehre and Young, {Karen C.} and Cristina Navarette and Ladino, {John F.} and Eduardo Bancalari and Cleide Suguihara",
year = "2005",
month = "3",
day = "1",
doi = "10.1203/01.PDR.0000150802.35283.27",
language = "English (US)",
volume = "57",
pages = "378--383",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

Effects of a nebulized NONOate, DPTA/NO, on group B Streptococcus-induced pulmonary hypertension in newborn piglets. / Dabrowska, Katarzyna; Hehre, Dorothy; Young, Karen C.; Navarette, Cristina; Ladino, John F.; Bancalari, Eduardo; Suguihara, Cleide.

In: Pediatric Research, Vol. 57, No. 3, 01.03.2005, p. 378-383.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effects of a nebulized NONOate, DPTA/NO, on group B Streptococcus-induced pulmonary hypertension in newborn piglets

AU - Dabrowska, Katarzyna

AU - Hehre, Dorothy

AU - Young, Karen C.

AU - Navarette, Cristina

AU - Ladino, John F.

AU - Bancalari, Eduardo

AU - Suguihara, Cleide

PY - 2005/3/1

Y1 - 2005/3/1

N2 - NONOates are chemical compounds that are stable as solids but generate nitric oxide (NO) in aqueous solutions. When nebulized or instilled intratracheally, NONOates can attenuate pulmonary hypertension in adult animals with lung injury. To assess the effect of a nebulized NONOate, DPTA/NO, on group B Streptococcus (GBS)-induced pulmonary hypertension in newborn piglets, we studied 20 anesthetized and mechanically ventilated piglets (4-10 d). They were randomly assigned to receive nebulized placebo solution or DPTA/NO (100 mg) 15 min after sustained pulmonary hypertension. Pulmonary artery and wedge, systemic, and right atrial pressures; cardiac output; and arterial blood gases were obtained at baseline and every 15 min during 120 min of continuous GBS infusion (6 × 108 CFU/min). Methemoglobin levels were measured at baseline and 60 min. A significant decrease in pulmonary artery pressure, pulmonary vascular resistance (PVR), systemic arterial pressure, and systemic vascular resistance (SVR) was observed after DPTA/NO nebulization (p < 0.001). Whereas the increase in PVR/SVR observed after GBS infusion was sustained for 120 min in the placebo group, this ratio decreased after DPTA/NO nebulization and remained significantly lower throughout the study period (p < 0.01). Cardiac output, arterial blood gases, and methemoglobin values did not differ between groups. These data demonstrate that the pulmonary hypertension induced by GBS infusion is markedly attenuated by DPTA/NO nebulization. The lower PVR/SVR observed in the treated group indicates that the vasodilatory effect of NONOate is more pronounced in the pulmonary than systemic vasculature. Therefore, NONOates may have clinical application in the management of pulmonary hypertension secondary to sepsis in neonates.

AB - NONOates are chemical compounds that are stable as solids but generate nitric oxide (NO) in aqueous solutions. When nebulized or instilled intratracheally, NONOates can attenuate pulmonary hypertension in adult animals with lung injury. To assess the effect of a nebulized NONOate, DPTA/NO, on group B Streptococcus (GBS)-induced pulmonary hypertension in newborn piglets, we studied 20 anesthetized and mechanically ventilated piglets (4-10 d). They were randomly assigned to receive nebulized placebo solution or DPTA/NO (100 mg) 15 min after sustained pulmonary hypertension. Pulmonary artery and wedge, systemic, and right atrial pressures; cardiac output; and arterial blood gases were obtained at baseline and every 15 min during 120 min of continuous GBS infusion (6 × 108 CFU/min). Methemoglobin levels were measured at baseline and 60 min. A significant decrease in pulmonary artery pressure, pulmonary vascular resistance (PVR), systemic arterial pressure, and systemic vascular resistance (SVR) was observed after DPTA/NO nebulization (p < 0.001). Whereas the increase in PVR/SVR observed after GBS infusion was sustained for 120 min in the placebo group, this ratio decreased after DPTA/NO nebulization and remained significantly lower throughout the study period (p < 0.01). Cardiac output, arterial blood gases, and methemoglobin values did not differ between groups. These data demonstrate that the pulmonary hypertension induced by GBS infusion is markedly attenuated by DPTA/NO nebulization. The lower PVR/SVR observed in the treated group indicates that the vasodilatory effect of NONOate is more pronounced in the pulmonary than systemic vasculature. Therefore, NONOates may have clinical application in the management of pulmonary hypertension secondary to sepsis in neonates.

UR - http://www.scopus.com/inward/record.url?scp=14344259862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14344259862&partnerID=8YFLogxK

U2 - 10.1203/01.PDR.0000150802.35283.27

DO - 10.1203/01.PDR.0000150802.35283.27

M3 - Article

C2 - 15585676

AN - SCOPUS:14344259862

VL - 57

SP - 378

EP - 383

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 3

ER -